The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fertility Drugs Market Research Report 2025
Synopsis
Fertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.
The global Fertility Drugs market was valued at US$ 5586 million in 2023 and is anticipated to reach US$ 9394 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
The fertility drugs market is driven by the increasing prevalence of infertility, delayed pregnancies, and the growing awareness and acceptance of assisted reproductive technologies (ART). Fertility drugs, such as Clomiphene, Gonadotropins, and Metformin, are widely used to stimulate ovulation and enhance the chances of conception in women struggling with infertility. Additionally, advancements in medical technology and research have led to the development of more effective and targeted fertility drugs, further propelling market growth. However, challenges include the high cost of fertility treatments, potential side effects of the drugs, and varying success rates among individuals. Addressing these challenges through cost-effective treatment options, personalized therapies, and continuous research to improve treatment outcomes will be essential for the sustained growth of the fertility drugs market.
This report aims to provide a comprehensive presentation of the global market for Fertility Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fertility Drugs.
Report Scope
The Fertility Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fertility Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fertility Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Ferring
MSD
LIVZON
Abbott
Bayer
Zydus Pharma
Segment by Type
Gonadotropins
Anti-Estrogens
Other
Segment by Application
Male
Female
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fertility Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fertility Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Fertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.
The global Fertility Drugs market was valued at US$ 5586 million in 2023 and is anticipated to reach US$ 9394 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
The fertility drugs market is driven by the increasing prevalence of infertility, delayed pregnancies, and the growing awareness and acceptance of assisted reproductive technologies (ART). Fertility drugs, such as Clomiphene, Gonadotropins, and Metformin, are widely used to stimulate ovulation and enhance the chances of conception in women struggling with infertility. Additionally, advancements in medical technology and research have led to the development of more effective and targeted fertility drugs, further propelling market growth. However, challenges include the high cost of fertility treatments, potential side effects of the drugs, and varying success rates among individuals. Addressing these challenges through cost-effective treatment options, personalized therapies, and continuous research to improve treatment outcomes will be essential for the sustained growth of the fertility drugs market.
This report aims to provide a comprehensive presentation of the global market for Fertility Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fertility Drugs.
Report Scope
The Fertility Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fertility Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fertility Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Ferring
MSD
LIVZON
Abbott
Bayer
Zydus Pharma
Segment by Type
Gonadotropins
Anti-Estrogens
Other
Segment by Application
Male
Female
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fertility Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fertility Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Fertility Drugs Market Overview
1.1 Product Overview and Scope of Fertility Drugs
1.2 Fertility Drugs Segment by Type
1.2.1 Global Fertility Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Gonadotropins
1.2.3 Anti-Estrogens
1.2.4 Other
1.3 Fertility Drugs Segment by Application
1.3.1 Global Fertility Drugs Market Value by Application: (2024-2030)
1.3.2 Male
1.3.3 Female
1.4 Global Fertility Drugs Market Size Estimates and Forecasts
1.4.1 Global Fertility Drugs Revenue 2019-2030
1.4.2 Global Fertility Drugs Sales 2019-2030
1.4.3 Global Fertility Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Fertility Drugs Market Competition by Manufacturers
2.1 Global Fertility Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Fertility Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Fertility Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Fertility Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fertility Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fertility Drugs, Product Type & Application
2.7 Fertility Drugs Market Competitive Situation and Trends
2.7.1 Fertility Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fertility Drugs Players Market Share by Revenue
2.7.3 Global Fertility Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fertility Drugs Retrospective Market Scenario by Region
3.1 Global Fertility Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Fertility Drugs Global Fertility Drugs Sales by Region: 2019-2030
3.2.1 Global Fertility Drugs Sales by Region: 2019-2024
3.2.2 Global Fertility Drugs Sales by Region: 2025-2030
3.3 Global Fertility Drugs Global Fertility Drugs Revenue by Region: 2019-2030
3.3.1 Global Fertility Drugs Revenue by Region: 2019-2024
3.3.2 Global Fertility Drugs Revenue by Region: 2025-2030
3.4 North America Fertility Drugs Market Facts & Figures by Country
3.4.1 North America Fertility Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Fertility Drugs Sales by Country (2019-2030)
3.4.3 North America Fertility Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Fertility Drugs Market Facts & Figures by Country
3.5.1 Europe Fertility Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Fertility Drugs Sales by Country (2019-2030)
3.5.3 Europe Fertility Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fertility Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Fertility Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Fertility Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Fertility Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Fertility Drugs Market Facts & Figures by Country
3.7.1 Latin America Fertility Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Fertility Drugs Sales by Country (2019-2030)
3.7.3 Latin America Fertility Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fertility Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Fertility Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Fertility Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Fertility Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Fertility Drugs Sales by Type (2019-2030)
4.1.1 Global Fertility Drugs Sales by Type (2019-2024)
4.1.2 Global Fertility Drugs Sales by Type (2025-2030)
4.1.3 Global Fertility Drugs Sales Market Share by Type (2019-2030)
4.2 Global Fertility Drugs Revenue by Type (2019-2030)
4.2.1 Global Fertility Drugs Revenue by Type (2019-2024)
4.2.2 Global Fertility Drugs Revenue by Type (2025-2030)
4.2.3 Global Fertility Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Fertility Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Fertility Drugs Sales by Application (2019-2030)
5.1.1 Global Fertility Drugs Sales by Application (2019-2024)
5.1.2 Global Fertility Drugs Sales by Application (2025-2030)
5.1.3 Global Fertility Drugs Sales Market Share by Application (2019-2030)
5.2 Global Fertility Drugs Revenue by Application (2019-2030)
5.2.1 Global Fertility Drugs Revenue by Application (2019-2024)
5.2.2 Global Fertility Drugs Revenue by Application (2025-2030)
5.2.3 Global Fertility Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Fertility Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Fertility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Fertility Drugs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Ferring
6.2.1 Ferring Corporation Information
6.2.2 Ferring Description and Business Overview
6.2.3 Ferring Fertility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ferring Fertility Drugs Product Portfolio
6.2.5 Ferring Recent Developments/Updates
6.3 MSD
6.3.1 MSD Corporation Information
6.3.2 MSD Description and Business Overview
6.3.3 MSD Fertility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 MSD Fertility Drugs Product Portfolio
6.3.5 MSD Recent Developments/Updates
6.4 LIVZON
6.4.1 LIVZON Corporation Information
6.4.2 LIVZON Description and Business Overview
6.4.3 LIVZON Fertility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LIVZON Fertility Drugs Product Portfolio
6.4.5 LIVZON Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Corporation Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Fertility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Abbott Fertility Drugs Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Fertility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bayer Fertility Drugs Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Zydus Pharma
6.6.1 Zydus Pharma Corporation Information
6.6.2 Zydus Pharma Description and Business Overview
6.6.3 Zydus Pharma Fertility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zydus Pharma Fertility Drugs Product Portfolio
6.7.5 Zydus Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fertility Drugs Industry Chain Analysis
7.2 Fertility Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fertility Drugs Production Mode & Process
7.4 Fertility Drugs Sales and Marketing
7.4.1 Fertility Drugs Sales Channels
7.4.2 Fertility Drugs Distributors
7.5 Fertility Drugs Customers
8 Fertility Drugs Market Dynamics
8.1 Fertility Drugs Industry Trends
8.2 Fertility Drugs Market Drivers
8.3 Fertility Drugs Market Challenges
8.4 Fertility Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
